- Its proprietary progressive polymer expertise reduces bacterial bioburden with out triggering antimicrobial resistance, one of many prime world public well being threats
- The Superior Wound Dressing (AWD) market is valued at 4.5 billion USD and is witnessing growing demand and technological developments
- The corporate is seeking to increase improvement and industrial collaborations with business leaders
BERN, Switzerland, Feb. 11, 2024 /PRNewswire/ — Polaroid Therapeutics, a Swiss-based biotech start-up, is growing superior antimicrobial therapies to reinforce affected person outcomes worldwide. As we speak, the corporate is happy to announce the achievement of great pre-clinical milestones in growing its progressive medical machine.
Polaroid Therapeutics is making a pioneering antimicrobial polymer expertise. These secure and extremely potent polymers disrupt bacterial cells in a singular mechanism of motion. They’ve a direct and long-lasting exercise with out inflicting antimicrobial resistance (AMR).
As we speak, the misuse and overuse of antimicrobials are the primary drivers of AMR. When antibiotics and antimicrobial brokers are used excessively or inappropriately, micro organism, viruses, fungi, and parasites can adapt to them, making these remedies much less efficient over time. In line with the World Well being Group, AMR is likely one of the prime world public well being and improvement threats. It’s estimated that bacterial AMR was straight liable for 1.27 million world deaths in 2019 and contributed to 4.95 million deaths. 
Originating from Polaroid, the model that pioneered the chemistry behind analog on the spot images, Polaroid Therapeutics’ mission is to create a extra human and significant world by way of cutting-edge expertise and analysis. The corporate is seeking to increase collaborations with business leaders in superior wound care, develop superior healthcare merchandise, and champion a patient-centric care system that units new requirements in medical remedy and affected person expertise.
Globally, 1-2% of the inhabitants suffers from continual wound issues annually. This variety of affected sufferers will enhance as world populations proceed to age. As we acknowledge the rising want for continual wound administration, there’s a important alternative to advance healthcare practices. By prioritizing efficient remedy methods for continual wounds, we will improve affected person care and optimize healthcare assets. This proactive strategy isn’t just about enhancing affected person outcomes; it additionally represents a step in direction of a extra environment friendly and sustainable healthcare system globally.
The worldwide Superior Wound Dressing (AWD) market was valued at 4.5 billion (USD) in 2022 and is projected to increase at a compound annual progress charge (CAGR) of 4.5% from 2023 to 2030, with antimicrobial merchandise representing 1 / 4 of the overall AWD market. The market is witnessing growing demand pushed by technological developments, surgical procedures, and the rising prevalence of continual wounds. This presents a chance for Polaroid Therapeutics and its companions to capitalize on superior product improvement and an unwavering deal with enhancing affected person outcomes. Because the market continues to evolve, alternatives for innovation and collaboration are ripe, positioning the business – and thought leaders like Polaroid Therapeutics – for sustained progress and development.
Ran Frenkel, CEO and Co-Founding father of Polaroid Therapeutics stated, “We’re working in an extremely advanced area. Globally, the medical wants stay unmet, which means sufferers are susceptible to extreme long-term issues. At Polaroid Therapeutics, we intention to vary this. Our applied sciences will profit each sufferers and the broader care ecosystem and, in flip, reposition continual wound care as not merely the administration of, however efficient answer. Individuals are struggling and we consider we will alleviate this on a world scale.”
About Polaroid Therapeutics:
Polaroid Therapeutics is a Swiss-based biotech start-up within the improvement of progressive antimicrobial expertise. Incubated and spun off by Polaroid, the model that pioneered the chemistry behind analogue on the spot images. Polaroid Therapeutics’ mission is to convey to life the perfect of Polaroid’s imaginative and prescient of making a extra human and significant world by way of cutting-edge expertise and analysis.
Based in 2022, Polaroid Therapeutics is growing antimicrobial therapies primarily based on proprietary antibacterial expertise to stop and inhibit infections in a number of indications, resembling acute and continual wounds. This distinctive expertise is a breakthrough answer that doesn’t create antimicrobial resistance (AMR) – thought to be probably the most distinguished world menace to well being.
Picture – https://mma.prnewswire.com/media/2338334/Polaroid_Therapeutics__Core_Tech_Asset.jpg
Emblem – https://mma.prnewswire.com/media/2338335/Polaroid_Theraphuetics_Logo.jpg
 World Well being Organisation
 Lindholm, C. and Searle, R. (2016) ‘Wound administration for the twenty first century: combining effectiveness and effectivity,’ Worldwide Wound Journal, 13(S2), pp. 5–15. https://doi.org/10.1111/iwj.12623.
3 BioMedGPS© 2022 World Superior Wound Dressing www.smarttrak.com